Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and Therapy
Hastings Center Report
Faden et al discuss the forthcoming transition of stem cell research from basic science to the development of therapies, which raises important questions of justice. They argue that they have great therapies and only a limited assortment of patients to give them to: the therapies would work only for patients whose immune systems are compatible with the stem cell lines from which the therapies are derived. If they develop therapies from cell lines that are compatible with the largest possible segments of the population, they will tend to benefit primarily whites.
Faden, Ruth R.; Liza Dawson; Alison S. Bateman-House; Dawn Mueller Agnew; Hilary Bok; Dan W. Brock; Aravinda Chakravarti; Xiaojiang Gao; Mark Greene; Patricia A. King; Stephen J. O'Brien; David H. Sachs; Kathryn E. Schill; Andrew Siegel; Davor Solter; Sonia M. Suter; Catherine M. Verfaillie; LeRoy B. Walters; and John Gearhart. 2003. "Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and Therapy." Hastings Center Report 33, (6): 13-27. http://nsuworks.nova.edu/cnso_bio_facarticles/562